An Early Phase 2 Study of KW-6356 in Subject with Early Parkinson's Disease.
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2018
At a glance
- Drugs KW 6356 (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 19 Mar 2018 Status changed from active, no longer recruiting to completed.
- 05 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Oct 2016 New trial record